InvestorsHub Logo
Followers 1037
Posts 115521
Boards Moderated 13
Alias Born 06/10/2006

Re: stockless post# 27515

Saturday, 01/31/2015 10:00:23 AM

Saturday, January 31, 2015 10:00:23 AM

Post# of 55245
They have been stating that they needed money for trialing to be able to submit for FDA approval. None of their financials show any funds ever going for trialing. EVER. Only for toxic debt. That is why the shares went from 156 million to possibly over TWO BILLION in the past year!


Convertible Loan Note debt has been applied for, providing a claim on 330 million reserved Common Stock shares at par value

Total shares outstanding: Common shares 1,184,894,145 09/30/2014

Convertible Loan Note debt has been applied for, providing a claim on 330 million reserved Common Stock shares at par value

Plus 117,500,000 ISSUED TO Blackbridge Capital, LLC

BASED ON THE ABOVE, MINIMUM O/S SHOULD BE 1,632,394,145 A/O 12/8/2014



Anything said by me is strictly my opinion and is subject to change without notice. I am not a financial planner or advisor.